OmniActive Secures EU Non-Novel Status for Lutemax 2020 

A key addition to our extensive global regulatory acceptance

EU Flag

Mumbai, India and Bridgewater, N.J. (May 14, 2025) Today, OmniActive Health Technologies (OmniActive) announces that its flagship ingredient, Lutemax 2020, has received formal recognition as non-novel for use in food supplements by the competent authorities of an EU Member State. This determination, made under the European Union’s Novel Food Regulation (EU) 2015/2283, affirms the ingredient’s established history of safe use and paves the way for broader commercialization across the European market. 

“This achievement reflects our commitment to rigorous compliance and scientific integrity,” said Arpita Tamhankar, Director of Regulatory Affairs at OmniActive. “The non-novel status reaffirms Lutemax 2020’s established safety profile and reinforces its position a leading macular carotenoid ingredient for European markets.” 

Lutemax 2020 is a patented, clinically studied ingredient sourced from marigold flowers, delivering all three macular carotenoids—lutein, RR-zeaxanthin, and RS (meso)-zeaxanthin—in a similar 5:1 ratio as found in the diet. Its efficacy in supporting visual performance, blue light protection, cognitive health and more, has been demonstrated in 10 peer-reviewed clinical study publications.  

“European customers can now confidently incorporate Lutemax 2020 into their products knowing it meets safety and transparency standards, said Akhil Bajaj, Divisional Vice President, Category Management. 

In light of this milestone, OmniActive plans to expand its “Lutein for Every Age” campaign into the European market later this year. Originally launched in the U.S. in 2023, the initiative aims to educate consumers and healthcare professionals about the lifelong benefits of consistent lutein and zeaxanthin intake for eye and cognitive health. This expansion underscores the company’s commitment to advancing global awareness of the benefits of Lutemax 2020, its flagship ingredient. 

OmniActive will showcase its Lutemax 2020 product portfolio, which is available globally, branded ingredient solutions, and botanical actives at Vitafoods Europe 2025 in Barcelona at Booth #4J27. To learn more about OmniActive, visit omniactives.com. 

About OmniActive   

Established in 2005, OmniActive seeks to improve lives through innovative science and natural health solutions. OmniActive’s product portfolio consists of scientifically validated, IP-protected, branded Specialty Actives and an extensive portfolio of natural Botanical Actives for global customers in the dietary supplement, functional food, and beverage markets. The company has offices in Mumbai, India, and Bridgewater, New Jersey.   

 

### 

Lutemax 2020 is a trademark of OmniActive Health Technologies, Ltd.